Replies to post #13131 on ANI Pharmaceuticals (ANIP)

[Just the facts maam]

LD, I agree a CRL is unlikely. They have been in communication with the FDA and went above and beyond what they said they would be looking for in Corti. If it is an extended PDUFA hopefully they can blame the backlog, negating any negative connotation to the delay.